Literature DB >> 32787112

Non-naturally Occurring Regio Isomer of Lysophosphatidylserine Exhibits Potent Agonistic Activity toward G Protein-Coupled Receptors.

Sho Nakamura1, Misa Sayama1, Akiharu Uwamizu2,3,4, Sejin Jung1, Masaya Ikubo1, Yuko Otani1, Kuniyuki Kano2,3,4, Jumpei Omi2,3,4, Asuka Inoue3,5,4, Junken Aoki2,3,4,6, Tomohiko Ohwada1.   

Abstract

Lysophosphatidylserine (LysoPS), an endogenous ligand of G protein-coupled receptors, consists of l-serine, glycerol, and fatty acid moieties connected by phosphodiester and ester linkages, respectively. An ester linkage of phosphatidylserine can be hydrolyzed at the 1-position or at the 2-position to give 2-acyl lysophospholipid or 1-acyl lysophospholipid, respectively. 2-Acyl lysophospholipid is in nonenzymatic equilibrium with 1-acyl lysophospholipid in vivo. On the other hand, 3-acyl lysophospholipid is not found, at least in mammals, raising the question of whether the reason for this might be that the 3-acyl isomer lacks the biological activities of the other isomers. Here, to test this idea, we designed and synthesized a series of new 3-acyl lysophospholipids. Structure-activity relationship studies of more than 100 "glycol surrogate" derivatives led to the identification of potent and selective agonists for LysoPS receptors GPR34 and P2Y10. Thus, the non-natural 3-acyl compounds are indeed active and appear to be biologically orthogonal with respect to the physiologically relevant 1- and 2-acyl lysophospholipids.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32787112     DOI: 10.1021/acs.jmedchem.0c01126

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition.

Authors:  Keiko Fukasawa; Mari Gotoh; Akiharu Uwamizu; Takatsugu Hirokawa; Masaki Ishikawa; Yoshibumi Shimizu; Shinji Yamamoto; Kensuke Iwasa; Keisuke Yoshikawa; Junken Aoki; Kimiko Murakami-Murofushi
Journal:  Sci Rep       Date:  2021-08-30       Impact factor: 4.379

Review 2.  Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive Lipid.

Authors:  Jumpei Omi; Kuniyuki Kano; Junken Aoki
Journal:  Cell Biochem Biophys       Date:  2021-06-15       Impact factor: 2.194

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.